Hereditary Angioedema Awareness

Douglas H. Jones, MD

Jones reports no relevant financial disclosures.
May 15, 2024
1 min watch
Save

VIDEO: Heavy activity in hereditary angioedema drug pipeline

Transcript

Editor’s note: This is an automatically generated transcript. Please notify editor@healio.com if there are concerns regarding accuracy of the transcription.

In terms of approved drugs, I think there's about eight or nine, just off the top of my head, that's currently approved, and we have almost double that, that's in the pipeline, just like in the current pipeline, coming down the track. So, you know, it took us decades and decades to even get one HAE-approved medicine. That evolved over the last decade, decade and a half to, again, where we have eight or nine, but the pipeline has close to double that amount. So, there's a lot, and, you know, there's a lot of different types of HAE medicines, some are oral, some are subcutaneous, some are IV, like, including, like, a gene therapy. So, there's a lot that's happening in this space.